Skip to main content

Among the challenges are moments of joy.

The federal government is committed to making every day better for people with dementia, their caregivers, and their families.

 

Find out how we’re taking action.

Why Participate in a Clinical Trial?

When you volunteer for a clinical trial, you help bring us closer to Alzheimer’s treatment and prevention discoveries.

News & Events

Richard Hodes
NIA statement on proposed CMS Medicare coverage decision for aducanumab to treat Alzheimer’s
Read the NIA Director's statement on CMS's coverage decision on monoclonal antibody treatments for Alzheimer's and related dementias.
Computer screens and a microscope in a DNA research laboratory.
Study maps out genomic regions that may control levels of proteins linked to neurological disorders
A new study maps out genomic regions that may control the levels of proteins linked to neurological disorders.
A pile of pills and tablets
Repurposed cancer treatments could be potential Alzheimer’s drugs
A pair of existing cancer drugs, one FDA-approved and another still experimental, showed promise for being repurposed as therapies in Alzheimer’s disease.